Use of 99mTc Tilmanocept for Imaging Arterial Inflammation
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Tc 99m tilmanocept (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use; First in man
- 18 Jan 2018 Planned number of patients changed from 24 to 31.
- 09 Oct 2017 New trial record
- 15 Apr 2017 Status changed from recruiting to completed as per the results published in the Journal of Infectious Diseases.